Sirtinol promotes PEPCK1 degradation and inhibits gluconeogenesis by inhibiting deacetylase SIRT2. [electronic resource]
Producer: 20190205Description: 7 p. digitalISSN:- 2045-2322
- Acetylation
- Animals
- Benzamides -- pharmacology
- Blood Glucose
- Gluconeogenesis -- drug effects
- HEK293 Cells
- Humans
- Hypoglycemic Agents -- pharmacology
- Intracellular Signaling Peptides and Proteins -- metabolism
- Liver -- metabolism
- Mice
- Naphthols -- pharmacology
- Phosphoenolpyruvate Carboxykinase (GTP) -- metabolism
- Sirtuin 2 -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.